University | Singapore University of Social Science (SUSS) |
Subject | BME215e: Clinical Trials |
BME215e: Clinical Trials Report, SUSS, Singapore The ongoing global pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections is causing deaths daily
Question 1
The ongoing global pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections is causing deaths daily since its origin. Various researchers and pharmaceutical companies have developed a number of vaccines to fight this coronavirus.
(a) As a clinical trial student, you are required to prepare a report on one (your choice) of the approved in-market vaccines used under the Singapore’s National Vaccination programme. The report should include the following information.
(I) Discuss in detail the vaccine development process involved/followed by the pharmaceutical company you have selected.
(ii) Analyze the pros and cons of their vaccine. Include in your write-up, information of the vaccine efficacy and adverse events.
(iii) What are your views on the selected vaccine? Include supporting details to back up your answer.
(b) Write a critical appraisal on any TWO (2) of the following published papers:
(I) McMenamin ME, Nealon J, Lin Yet al.. Vaccine effectiveness of one, two and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong: a population-based observational study. Lancet Infectious Diseases, 2022, https://doi.org/10.1016/S1473-3099(22)00345-0
(ii) Tandon M, Wu W, Moore K, Winchester S. SARS-CoV-2 accelerated clearance using a novel nitric oxide nasal spray (NONS) treatment: A randomized trial. The Lancet Regional Health-Southeast Asia, 2022; 00: 100036.
(iii) Daniel RF, Melissa M H, Laith J A-R, et al.. Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression. Lancet, 2022; 399: 924-44.
(iv) Moreira ED, Kitchin N, Xu X, Dychter SS et al., Safety and efficacy of a third dose of BNT162b2 COVID-19 vaccine. N Engl Med, 2022; 386:1910-21.
(v) Andrews N, Stowe J, Kirsebom F et al,. COVID-19 vaccine effectiveness against the Omicron (B1.1.1.529) variant. N Engl Med, 2022; 386: 1532-46.
Buy Custom Answer of This Assessment & Raise Your Grades
Ace Your BME215e Clinical Trials Report at SUSS! The ongoing global pandemic of SARS-CoV-2 infections has emphasized the importance of clinical trials. If you're facing challenges with your Clinical Trials report for BME215e at the Singapore University of Social Sciences (SUSS), worry not! Our assignment writing service in Singapore is designed to provide you with the support you need. Our expert writers have a strong background in clinical trials and understand the intricacies of the subject. With our Case Study Writing Help, you can confidently approach your report and secure high grades. Trust our reliable assignment help and pay our experts to take help on your course for exceptional results.
- A2329C Dosage Form Design AY2024 Term 4 – Graded Assignment (Individual Report), Singapore
- ANL312 Text Mining and Applied Project Formulation, End-of-Course Assessment, SUSS, Singapore
- CMM315 Peacebuilding and Security, End-of-Course Assessment, SUSS, Singapore
- HFS351 ECA (End-of-Course Assessment) SUSS : July Semester 2024 – Safety Management and Audit
- HFSY217 ECA (End-of-Course Assessment) SUSS : July Semester 2024 – Emergency Preparedness and Response Planning, Singapore
- NSG3EPN Assignment Two instructions rubric – Contemporary nursing practice :Engagement in Professional Nursing, LTU Singapore
- HFS201 GBA (Group-based Assignment) SUSS: July 2024 – Workplace Evaluation and Design
- Business Accounting & Finance – (VM) – A3 Assignment, UOM, Singapore
- HRM3010S: Managing People At Work, Assignment, UCD, Singapore
- HFS351: Safety Management and Audit, End-of-Course Assessment, SUSS, Singapore
UP TO 15 % DISCOUNT